Mark Clendenning

Mark Clendenning

UNVERIFIED PROFILE

Are you Mark Clendenning?   Register this Author

Register author
Mark Clendenning

Mark Clendenning

Publications by authors named "Mark Clendenning"

Are you Mark Clendenning?   Register this Author

79Publications

2584Reads

35Profile Views

Tumor mutational signatures in sebaceous skin lesions from individuals with Lynch syndrome.

Mol Genet Genomic Med 2019 Jul 4;7(7):e00781. Epub 2019 Jun 4.

Colorectal Oncogenomics Group, Department of Clinical Pathology, The University of Melbourne, Parkville, Vic., Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mgg3.781DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6625139PMC
July 2019

Correction: Risk of colorectal cancer for carriers of a germ-line mutation in POLE or POLD1.

Genet Med 2018 10;20(10):1299

Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Parkville, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/gim.2017.265DOI Listing
October 2018

Cancer Risks for PMS2-Associated Lynch Syndrome.

J Clin Oncol 2018 Oct 30;36(29):2961-2968. Epub 2018 Aug 30.

Sanne W. ten Broeke, Heleen M. van der Klift, Carli M.J. Tops, Manon Suerink, Frederik J. Hes, Hans F.A. Vasen, Juul T. Wijnen, and Maartje Nielsen, Leiden University Medical Center, Leiden; Encarna Gomez Garcia, Maastricht University Medical Center, Maastricht; Nicoline Hoogerbrugge, Arjen R. Mensenkamp, and Liesbeth Spruijt, Radboud University Medical Center, Nijmegen; Tom G.W. Letteboer, University Medical Center, Utrecht; Theo A.M. van Os and Egbert J.W. Redeker, Academic Medical Center, Amsterdam; Maran J.W. Olderode-Berends and Yvonne J. Vos, University of Groningen; University Medical Center Groningen, Groningen; Anja Wagner, Erasmus Medical Center, Rotterdam, the Netherlands; Stefan Aretz, University of Bonn; University Hospital Bonn, Bonn; Christoph Engel, Leipzig University; Medizinisch Genetisches Zentrum Bayerstr, Leipzig; Magnus von Knebel Doeberitz, University of Heidelberg; German Cancer Research Center, Heidelberg; Pål Møller, University of Witten-Herdecke, Wuppertal; Nils Rahner, Heinrich-Heine-University, Düsseldorf; Hans K. Schackert, Technische Universität Dresden, Dresden; Verena Steinke-Lange, Medizinische Klinik und Poliklinik IV Campus Innenstadt, Klinikum der Universität München, Munich, Germany; Pål Møller, The Norwegian Radium Hospital; Oslo University Hospital, Oslo, Norway; Inge Bernstein, Hvidovre Hospital, Hvidovre, and Aalborg University Hospital, Aalborg, Denmark; Daniel D. Buchanan, Mark Clendenning, John L. Hopper, Mark A. Jenkins, Christophe Rosty, Ingrid Winship, and Aung Ko Win, The University of Melbourne; Daniel D. Buchanan, Ingrid Winship, and Aung Ko Win, Royal Melbourne Hospital, Parkville, Melbourne, Victoria; Rodney Scott, University of Newcastle, Newcastle, New South Wales, Australia; Albert de la Chapelle, Heather L. Hampel, Rachel Pearlman, and Leigha Senter, The Ohio State University Comprehensive Cancer Center, Columbus, OH; Gabriel Capella and Marta Pineda, Institut d'Investigació Biomédica de Bellvitge, Barcelona, Spain; Steven Gallinger, Mount Sinai Hospital, Toronto, Ontario, Canada; Jane C. Figueiredo and Robert Haile, Cedars-Sinai Medical Center, Los Angeles, CA; Loic Le Marchand, University of Hawaii Cancer Center, Honolulu, HI; Annika Lindblom, Karolinska Institutet; Karolinska University Hospital, Stockholm, Sweden; Noralane M. Lindor, Mayo Clinic Arizona, Scottsdale, AZ; Polly A. Newcomb, Fred Hutchinson Cancer Research Center; University of Washington, Seattle, WA; and Stephen Thibodeau, Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2018.78.4777
Publisher Site
http://dx.doi.org/10.1200/JCO.2018.78.4777DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349460PMC
October 2018

Risk of colorectal cancer for carriers of a germ-line mutation in POLE or POLD1.

Genet Med 2018 08 9;20(8):890-895. Epub 2017 Nov 9.

Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Parkville, Victoria, Australia.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/gim2017185
Publisher Site
http://dx.doi.org/10.1038/gim.2017.185DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5943186PMC
August 2018

Identification of nine new susceptibility loci for endometrial cancer.

Authors:
Tracy A O'Mara Dylan M Glubb Frederic Amant Daniela Annibali Katie Ashton John Attia Paul L Auer Matthias W Beckmann Amanda Black Manjeet K Bolla Hiltrud Brauch Hermann Brenner Louise Brinton Daniel D Buchanan Barbara Burwinkel Jenny Chang-Claude Stephen J Chanock Chu Chen Maxine M Chen Timothy H T Cheng Christine L Clarke Mark Clendenning Linda S Cook Fergus J Couch Angela Cox Marta Crous-Bous Kamila Czene Felix Day Joe Dennis Jeroen Depreeuw Jennifer Anne Doherty Thilo Dörk Sean C Dowdy Matthias Dürst Arif B Ekici Peter A Fasching Brooke L Fridley Christine M Friedenreich Lin Fritschi Jenny Fung Montserrat García-Closas Mia M Gaudet Graham G Giles Ellen L Goode Maggie Gorman Christopher A Haiman Per Hall Susan E Hankison Catherine S Healey Alexander Hein Peter Hillemanns Shirley Hodgson Erling A Hoivik Elizabeth G Holliday John L Hopper David J Hunter Angela Jones Camilla Krakstad Vessela N Kristensen Diether Lambrechts Loic Le Marchand Xiaolin Liang Annika Lindblom Jolanta Lissowska Jirong Long Lingeng Lu Anthony M Magliocco Lynn Martin Mark McEvoy Alfons Meindl Kyriaki Michailidou Roger L Milne Miriam Mints Grant W Montgomery Rami Nassir Håkan Olsson Irene Orlow Geoffrey Otton Claire Palles John R B Perry Julian Peto Loreall Pooler Jennifer Prescott Tony Proietto Timothy R Rebbeck Harvey A Risch Peter A W Rogers Matthias Rübner Ingo Runnebaum Carlotta Sacerdote Gloria E Sarto Fredrick Schumacher Rodney J Scott V Wendy Setiawan Mitul Shah Xin Sheng Xiao-Ou Shu Melissa C Southey Anthony J Swerdlow Emma Tham Jone Trovik Constance Turman Jonathan P Tyrer Celine Vachon David VanDen Berg Adriaan Vanderstichele Zhaoming Wang Penelope M Webb Nicolas Wentzensen Henrica M J Werner Stacey J Winham Alicja Wolk Lucy Xia Yong-Bing Xiang Hannah P Yang Herbert Yu Wei Zheng Paul D P Pharoah Alison M Dunning Peter Kraft Immaculata De Vivo Ian Tomlinson Douglas F Easton Amanda B Spurdle Deborah J Thompson

Nat Commun 2018 08 9;9(1):3166. Epub 2018 Aug 9.

Department of Public Health and Primary Care, University of Cambridge, Centre for Cancer Genetic Epidemiology, Cambridge, CB1 8RN, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41467-018-05427-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6085317PMC
August 2018

Targeted sequencing of established and candidate colorectal cancer genes in the Colon Cancer Family Registry Cohort.

Oncotarget 2017 Nov 21;8(55):93450-93463. Epub 2017 Jun 21.

Colorectal Oncogenomics Group, Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, Victoria, Australia.

View Article

Download full-text PDF

Source
http://www.oncotarget.com/fulltext/18596
Publisher Site
http://dx.doi.org/10.18632/oncotarget.18596DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706810PMC
November 2017

Lack of evidence for germline mutations in patients with serrated polyposis syndrome from a large multinational study.

Gut 2017 06 31;66(6):1170-1172. Epub 2016 Aug 31.

Colorectal Oncogenomics Group, Genetic Epidemiology Laboratory, Department of Pathology, The University of Melbourne, Parkville, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/gutjnl-2016-312773DOI Listing
June 2017

Reducing the polyp burden in serrated polyposis by serial colonoscopy: the impact of nationally coordinated community surveillance.

N Z Med J 2017 03 3;130(1451):57-67. Epub 2017 Mar 3.

Department of Haematology and Oncology, The Queen Elizabeth Hospital, Australia, School of Medicine, University of Adelaide, Australia, SAHMRI Colorectal Node, Basil Hetzel Institute for Translational Research, Australia.

View Article

Download full-text PDF

Source
March 2017

Quantifying the utility of single nucleotide polymorphisms to guide colorectal cancer screening.

Future Oncol 2016 Feb 1;12(4):503-13. Epub 2016 Feb 1.

Centre for Epidemiology & Biostatistics, Melbourne School of Population & Global Health, The University of Melbourne, Parkville Victoria, VIC 3010, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon.15.303DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4976832PMC
February 2016

Genetic variants within the hTERT gene and the risk of colorectal cancer in Lynch syndrome.

Genes Cancer 2015 Nov;6(11-12):445-51

Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Parkville, Victoria, Australia; Colorectal Oncogenomics Group, Genetic Epidemiology Laboratory, Department of Pathology, The University of Melbourne, Parkville, Victoria, Australia.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4701223PMC
http://dx.doi.org/10.18632/genesandcancer.85DOI Listing
November 2015

Aspirin, Ibuprofen, and the Risk of Colorectal Cancer in Lynch Syndrome.

J Natl Cancer Inst 2015 Sep 24;107(9). Epub 2015 Jun 24.

Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Parkville, Victoria, Australia (DAO, SGD, RC, DDB, GGG, JLH, MAJ, AKW); Oncogenomics Group, Genetic Epidemiology Laboratory, Department of Pathology, The University of Melbourne, Parkville, Victoria, Australia (DDB, MC, CR); University of Queensland, School of Medicine, Herston, Queensland, Australia (CR); Department of Medicine, Royal Melbourne Hospital, The University of Melbourne, Parkville, Victoria, Australia (IMW, FAM); Genetic Medicine and Family Cancer Clinic, Royal Melbourne Hospital, Parkville, Australia (IMW, FAM); Departments of Haematology and Oncology, The Queen Elizabeth Hospital, Woodville, South Australia, Australia (JPY); SAHMRI Colorectal Node, Basil Hetzel Institute for Translational Research, Woodville, South Australia, Australia (JPY); School of Medicine, University of Adelaide, South Australia, Australia (JPY); Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Victoria, Australia (GGG); QIMR Berghofer Medical Research Institute, Royal Brisbane Hospital, Herston, Queensland, Australia (BL); Colorectal Medicine and Genetics, The Royal Melbourne Hospital, Parkville, Victoria, Australia (FAM); Department of Medicine, University of Colorado School of Medicine, Denver, CO (DJA); Department of Preventive Medicine, Keck School of Medicine and Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA (GC); Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada (SG); Department of Medicine, Division of Oncology, Stanford Cancer Institute, Stanford University, CA (RWH); University of Hawaii Cancer Center, Honolulu, HI (LLM); Molecular Genetics Laboratory, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (SNT); Department of Health Science Research, Mayo Clinic Arizona, Scottsdale, AZ (NML); Public Health Science

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djv170DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4651105PMC
September 2015

Do serrated neoplasms of the small intestine represent a distinct entity? Pathological findings and molecular alterations in a series of 13 cases.

Histopathology 2015 Feb 6;66(3):333-42. Epub 2015 Jan 6.

Envoi Pathology, Brisbane, Qld, Australia; School of Medicine, University of Queensland, Brisbane, Qld, Australia; Genetic Epidemiology Laboratory, Department of Pathology, The University of Melbourne, Carlton, Vic., Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.12469DOI Listing
February 2015

Should the grading of colorectal adenocarcinoma include microsatellite instability status?

Hum Pathol 2014 Oct 17;45(10):2077-84. Epub 2014 Jul 17.

Genetic Epidemiology Laboratory, Department of Pathology, The University of Melbourne, Carlton 3010, VIC, Australia; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Parkville, VIC 3010, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2014.06.020DOI Listing
October 2014

Clinical problems of colorectal cancer and endometrial cancer cases with unknown cause of tumor mismatch repair deficiency (suspected Lynch syndrome).

Appl Clin Genet 2014 6;7:183-93. Epub 2014 Oct 6.

Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Parkville, VIC, Australia.

View Article

Download full-text PDF

Source
http://www.dovepress.com/clinical-problems-of-colorectal-can
Publisher Site
http://dx.doi.org/10.2147/TACG.S48625DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4199650PMC
October 2014

Re: Microsatellite instability and BRAF mutation testing in colorectal cancer prognostication.

J Natl Cancer Inst 2014 Aug 11;106(8). Epub 2014 Aug 11.

Cancer and Population Studies Group, QIMR Berghofer Medical Research Institute, Australia (CR, MC, RJW, MDW, DDB); Oncogenomics Group, Genetic Epidemiology Laboratory, Department of Pathology, The University of Melbourne, Parkville, Australia (MC, DDB); University of Queensland, School of Medicine, Herston, Australia (CR); Envoi Pathology, Herston, Australia (CR); Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, Melbourne School of Population and Global Health, The University of Melbourne, Parkville, Australia (EJW, AKW, MAJ, JLH, GGG, DRE, DDB); Department of Histopathology, Sullivan Nicolaides Pathology, Taringa, Australia (MDW); Seoul National University, Seoul, Korea (JLH); Department of Medicine, The University of Melbourne, Parkville, Australia (IW); Genetic Medicine, The Royal Melbourne Hospital, Parkville, Australia (IW); Genetic Epidemiology Laboratory, Department of Pathology, The University of Melbourne, Carlton, Australia (MCS); Cancer Epidemiology Centre, Cancer Council Victoria, Carlton, Australia (GGG, DRE).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/dju180DOI Listing
August 2014

Tumor mismatch repair immunohistochemistry and DNA MLH1 methylation testing of patients with endometrial cancer diagnosed at age younger than 60 years optimizes triage for population-level germline mismatch repair gene mutation testing.

J Clin Oncol 2014 Jan 9;32(2):90-100. Epub 2013 Dec 9.

Daniel D. Buchanan, Yen Y. Tan, Michael D. Walsh, Mark Clendenning, Alexander M. Metcalf, Kaltin Ferguson, Sven T. Arnold, Bryony A. Thompson, Felicity A. Lose, Michael T. Parsons, Rhiannon J. Walters, Sally-Ann Pearson, Joanne P. Young, Penelope M. Webb, and Amanda B. Spurdle, QIMR Berghofer Medical Research Institute, Herston; Yen Y. Tan and Andreas Obermair, University of Queensland School of Medicine, Brisbane; Margaret Cummings, University of Queensland Centre for Clinical Research, Herston, Queensland; Martin K. Oehler, Royal Adelaide Hospital, Adelaide, South Australia; Michael A. Quinn, Royal Women's Hospital, Melbourne, Victoria; Judy A. Kirk, Westmead Institute for Cancer Research, Westmead Millennium Institute, University of Sydney, Sydney, New South Wales; Colin J. Stewart, King Edward Memorial Hospital, Perth, Western Australia, Australia; and Penelope B. Blomfield, Royal Hobart Hospital, Hobart, Tasmania.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2013/12/09/JCO.2013.51
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2013.51.2129
Publisher Site
http://dx.doi.org/10.1200/JCO.2013.51.2129DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876359PMC
January 2014

Expression of MUC2, MUC5AC, MUC5B, and MUC6 mucins in colorectal cancers and their association with the CpG island methylator phenotype.

Mod Pathol 2013 Dec 28;26(12):1642-56. Epub 2013 Jun 28.

1] Cancer and Population Studies Group, Queensland Institute of Medical Research, Herston, QLD, Australia [2] Department of Histopathology, Sullivan Nicolaides Pathology, Taringa, QLD, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2013.101DOI Listing
December 2013

BRAFV600E immunohistochemistry facilitates universal screening of colorectal cancers for Lynch syndrome.

Am J Surg Pathol 2013 Oct;37(10):1592-602

*Department of Anatomical Pathology †Northern Cancer Translational Research Unit ††Familial Cancer Clinic, Royal North Shore Hospital ∥Department of Pathology, SYDPATH, St Vincents Hospital, Darlinghurst ¶Faculty of Medicine, University of NSW ¶¶Sydney Medical School, University of Sydney, Sydney, NSW §§Department of Molecular and Cellular Pathology ‡Department of Pathology, School of Medicine, University of Queensland ‡‡Envoi Specialist Pathologists, Herston §Cancer and Population Studies Group, Queensland Institute of Medical Research, Brisbane, QLD ∥∥Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, School of Population Health, University of Melbourne, Carlton, Vic., Australia #Department of Neuropathology, Institute of Pathology, Ruprecht-Karls University **Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0b013e31828f233dDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3773060PMC
October 2013

Germline HOXB13 p.Gly84Glu mutation and risk of colorectal cancer.

Cancer Epidemiol 2013 Aug 26;37(4):424-7. Epub 2013 Mar 26.

Women's College Research Institute, Women's College Hospital, University of Toronto, Toronto, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canep.2013.03.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3684005PMC
August 2013

Mutation deep within an intron of MSH2 causes Lynch syndrome.

Fam Cancer 2011 Jun;10(2):297-301

Familial Cancer Laboratory, Queensland Institute of Medical Research, 300 Herston Road, Herston, QLD, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10689-011-9427-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4580736PMC
June 2011

Epitope-positive truncating MLH1 mutation and loss of PMS2: implications for IHC-directed genetic testing for Lynch syndrome.

Fam Cancer 2009 12;8(4):501-4. Epub 2009 Aug 12.

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Washington University School of Medicine and Siteman Cancer Center, St Louis, MO 63110, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10689-009-9276-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2771133PMC
January 2010

Café-au-lait macules and pediatric malignancy caused by biallelic mutations in the DNA mismatch repair (MMR) gene PMS2.

Pediatr Blood Cancer 2008 Jun;50(6):1268-70

Division of General Surgery, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.21514DOI Listing
June 2008

Long-range PCR facilitates the identification of PMS2-specific mutations.

Hum Mutat 2006 May;27(5):490-5

Human Cancer Genetics Program, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/humu.20318
Publisher Site
http://dx.doi.org/10.1002/humu.20318DOI Listing
May 2006